PhaseBio Pharmaceuticals Inc·4

Mar 1, 5:03 PM ET

van den Broek Richard 4

4 · PhaseBio Pharmaceuticals Inc · Filed Mar 1, 2019

Insider Transaction Report

Form 4
Period: 2019-02-27
Transactions
  • Award

    Non-employee Director Stock Option (right to buy)

    2019-02-27+23,00023,000 total
    Exercise: $3.15Exp: 2029-02-27Common Stock (23,000 underlying)
  • Award

    Non-employee Director Stock Option (right to buy)

    2019-02-27+22,00022,000 total
    Exercise: $3.15Exp: 2029-02-27Common Stock (22,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in equal monthly installments over 36 months from February 27, 2019, subject to the reporting person's continued service through each such date.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_838098

    POA DOCUMENT